Stocks · Health care · Pharmaceutical Preparations

Amylyx Pharmaceuticals, Inc.

AMLX Clue Score40
United States Fiscal year ends December CIK 0001658551 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
George M Milne Jr
5 Oct 2026
Director
Sold on a plan
30,000
$27.70
$830.90K
Joshua B Cohen
10 Sep 2026
Co-Chief Executive Officer
Sell
919
$33.15
$30.46K
Joshua B Cohen
10 Sep 2026
Co-Chief Executive Officer
Sell
29,545
$32.16
$950.04K
Justin B. Klee
10 Sep 2026
Co-Chief Executive Officer
Sell
1,439
$33.16
$47.71K
Justin B. Klee
10 Sep 2026
Co-Chief Executive Officer
Sell
29,025
$32.13
$932.55K
Gina Mazzariello
10 Sep 2026
Chief Legal Officer
Sell
11
$33.34
$366.74
Gina Mazzariello
10 Sep 2026
Chief Legal Officer
Sell
9,525
$32.46
$309.14K
James M Frates
10 Sep 2026
Chief Financial Officer
Sell
1,042
$33.23
$34.63K
James M Frates
10 Sep 2026
Chief Financial Officer
Sell
9,768
$32.27
$315.19K
Camille L Bedrosian
10 Sep 2026
Chief Medical Officer
Sell
2,081
$33.09
$68.86K
Camille L Bedrosian
10 Sep 2026
Chief Medical Officer
Sell
7,947
$32.21
$256.00K
Karen Firestone
31 Aug 2026
Director
Exercised, kept
25,000
$5.05
$126.25K
Karen Firestone
31 Aug 2026
Director
Exercised, kept
25,000
$1.76
$44.00K
Gina Mazzariello
10 Jul 2026
Chief Legal Officer
Sold on a plan
15,000
$17.61
$264.12K
Gina Mazzariello
9 Jul 2026
Chief Legal Officer
Sold on a plan
15,000
$18.32
$274.75K
Karen Firestone
21 May 2026
Director
Buy
3,800
$13.51
$51.34K
Gina Mazzariello
2 Mar 2026
Chief Legal Officer
Sell
6,844
$14.52
$99.38K
James M Frates
2 Mar 2026
Chief Financial Officer
Sell
7,909
$14.52
$114.85K
Camille L Bedrosian
2 Mar 2026
Chief Medical Officer
Sell
6,461
$14.58
$94.21K
Joshua B Cohen
2 Mar 2026
Co-Chief Executive Officer
Sell
29,282
$14.48
$424.12K
Justin B. Klee
2 Mar 2026
Co-Chief Executive Officer
Sell
29,282
$14.47
$423.76K
Gina Mazzariello
23 Feb 2026
Chief Legal Officer
Sell
3,419
$14.14
$48.35K
Justin B. Klee
2 Feb 2026
Co-Chief Executive Officer
Sell
15,500
$14.69
$227.62K
Gina Mazzariello
2 Feb 2026
Chief Legal Officer
Sell
3,448
$14.65
$50.52K
Joshua B Cohen
2 Feb 2026
Co-Chief Executive Officer
Sell
15,500
$14.68
$227.59K
James M Frates
2 Feb 2026
Chief Financial Officer
Sell
3,557
$14.65
$52.10K
Justin B. Klee
16 Jan 2026
Co-Chief Executive Officer
Sold after exercise
1,995
$13.89
$27.70K
Joshua B Cohen
16 Jan 2026
Co-Chief Executive Officer
Sold after exercise
1,974
$13.83
$27.30K
Justin B. Klee
15 Jan 2026
Co-Chief Executive Officer
Sold after exercise
136,193
$13.58
$1.85M
Joshua B Cohen
15 Jan 2026
Co-Chief Executive Officer
Sold after exercise
136,193
$13.59
$1.85M
Justin B. Klee
6 Jan 2026
Co-Chief Executive Officer
Sell
7,715
$11.09
$85.59K
Joshua B Cohen
6 Jan 2026
Co-Chief Executive Officer
Sell
7,715
$11.09
$85.60K
James M Frates
6 Jan 2026
Chief Financial Officer
Sell
3,326
$11.11
$36.95K
Karen Firestone
23 Dec 2025
Director
Buy
8,100
$12.45
$100.85K
Camille L Bedrosian
1 Dec 2025
Chief Medical Officer
Sell
6,580
$14.35
$94.42K

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 4
Sales at will 24
Transactions with no price 0
Shares from compensation/vesting 1,419,126
History held since 10 Jan 2022